On Tuesday, Coeur Mining Inc (NYSE:CDE)’s shares declined -0.52% to $5.79.
Coeur Mining Inc (CDE) declared proven and probable reserves at the recently-attained Wharf gold mine in South Dakota of about 781,000 gold ounces. This represents a 39% enhance from the last stated reserve estimate at Wharf by Goldcorp from year-end 2013 of 560,000 ounces. The addition of these new reserves at Wharf results in a 35% enhance in Coeur’s total gold reserves to 3.0 million ounces.
Mitchell J. Krebs, Coeur’s President and Chief Executive Officer, said, “Given the importance of Wharf to our Company, we felt it was necessary to take the time to complete a more informed resource model based on pre-existing data to improve our mine planning and ability to execute according to plan. We were optimistic that this effort would result in additional reserves based on the mine’s history of positive reconciliations between the reserve model and production. The results have surpassed our expectations by adding three years of predictable mine life, making Wharf a key producing asset for Coeur for at least the next decade. We are optimistic that exploration efforts now underway around the existing open pit will further add to Wharf’s reserves.”
Coeur Mining, Inc., through its auxiliaries, engages in the ownership, operation, exploration, and development of silver and gold mining properties primarily in the United States, Mexico, Bolivia, Argentina, Australia, Ecuador, Chile, and New Zealand. Its principal properties comprise the Palmarejo silver and gold mine in Mexico; San Bartolomé silver mine in Bolivia; Kensington gold mine located in Alaska; the Rochester silver and gold mine in Nevada; and the Endeavor mine, an underground zinc, lead, and silver mine in Australia.
Spirit Airlines Incorporated (NASDAQ:SAVE)’s shares gained 1.32% to $65.38.
Spirit Airlines Incorporated (SAVE) declared that its shareholders have elected Dawn M. Zier as its newest board member, effective June 16, 2015.
Since November 2012, Ms. Zier has served as President and Chief Executive Officer of Nutrisystem Inc., a leading commercial provider of weight loss products and services, and as a member of its board of directors. She has led the turnaround of Nutrisystem by successfully changing the trajectory of the business and delivering customer and shareholder value with seven successive quarters of year-over-year growth. An engineer by education, Ms. Zier has spent most of her career in marketing, keeping her finger on the pulse of global consumers. Before joining Nutrisystem, Ms. Zier spent 20 years at Reader’s Digest Association, a global media and direct marketing company, serving in a range of leadership positions, most recently as president of the company’s international business. Before joining RDA, Ms. Zier held positions at AT&T, Chase Manhattan Bank, and Prodigy Services Corporation. She has an MBA from the MIT Sloan School of Administration in addition to a Master’s of Science degree in Electrical Engineering and Computer Science from MIT. She received her Bachelor’s of Engineering degree in Electrical Engineering and Computer Science from the State University of New York at Stony Brook.
Spirit Airlines, Inc. provides low-fare airline services. As of February 17, 2015, it operated about 325 daily flights to 57 destinations in the United States, Caribbean, and Latin America. As of December 31, 2014, the company had a fleet of 65 Airbus single-aisle aircraft comprising 29 A319s, 34 A320s, and 2 A321s. Spirit Airlines, Inc. was founded in 1964 and is headquartered in Miramar, Florida.
At the end of Tuesday’s trade, Prima Biomed Ltd. (NASDAQ:PBMD)‘s shares showed no change to $1.72.
Prima Biomed Ltd. (PBMD) declared that it has received EUR 226,055 (about A$320,000) in a cash rebate from the French state under the Crédit d’Impôt Recherche scheme. The cash rebate was paid in respect of expenditure incurred by Prima’s wholly owned partner, Immutep on French R&D activities in the 2014 calendar year, related to the Company’s LAG-3 programs.
Prima is eligible to receive CIR credits because it has a laboratory at Châtenay-Malabry in southwestern Paris. The laboratory is a leading centre of immunology research in Europe. The Châtenay-Malabry facility is headed by Chief Scientific and Medical Officer Professor Frédéric Triebel. Prima inherited the laboratory with its December 2014 acquisition of the French company Immutep SA. It is presently working on new products in addition to development of the existing Prima pipeline, which comprises the lead compound IMP321 entering Phase IIb trial in metastatic breast cancer patients receiving first-line chemotherapy.
Prima BioMed Ltd. researches, develops, and commercializes medical biotechnology products in Australia. The company develops immunocellular therapeutic products for the treatment of cancer. Its lead product is CVac, an autologous dendritic cell-based product presently in clinical trials for ovarian and pancreatic cancer patients. Prima BioMed Ltd. is based in Sydney, Australia.
Ares Capital Corporation (NASDAQ:ARCC), ended its Tuesday’s trading session with 0.36% gain, and closed at $16.66.
Ares Capital Corporation (ARCC) and Varagon Capital Partners recently declared that they are establishing a new joint venture that will make senior secured loans to middle-market companies. The new joint venture will be called the Senior Direct Lending Program (SDLP). The SDLP will work to follow on with the success that Ares Capital enjoyed with its previous senior loan joint venture, the Senior Secured Loan Program (SSLP), with GE Capital.
Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
